Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

BUY
$306.88 - $380.0 $38,973 - $48,260
127 Added 20.06%
760 $287,000
Q3 2023

Nov 09, 2023

SELL
$315.92 - $397.36 $631 - $794
-2 Reduced 0.31%
633 $201,000
Q2 2023

Aug 09, 2023

SELL
$346.15 - $392.09 $8,307 - $9,410
-24 Reduced 3.64%
635 $243,000
Q1 2023

May 11, 2023

SELL
$323.56 - $373.36 $2,588 - $2,986
-8 Reduced 1.2%
659 $246,000
Q4 2022

Jan 25, 2023

BUY
$248.67 - $334.17 $165,862 - $222,891
667 New
667 $221,000
Q2 2022

Aug 12, 2022

SELL
$301.4 - $428.42 $178,127 - $253,196
-591 Closed
0 $0
Q1 2022

Apr 27, 2022

BUY
$379.46 - $424.54 $13,660 - $15,283
36 Added 6.49%
591 $247,000
Q4 2021

Feb 11, 2022

SELL
$373.53 - $434.12 $5,976 - $6,945
-16 Reduced 2.8%
555 $233,000
Q3 2021

Nov 12, 2021

BUY
$396.76 - $455.92 $13,489 - $15,501
34 Added 6.33%
571 $236,000
Q2 2021

Aug 10, 2021

BUY
$372.36 - $412.07 $199,957 - $221,281
537 New
537 $213,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Greenleaf Trust Portfolio

Follow Greenleaf Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.